Individuals will obtain answers to the following questions:
Is there evidence of a prior infection?
Is there evidence that a robust immune response was developed from either infection or vaccination?
Is there evidence the immune response can provide a level of protected immunity against COVID-19?
The SARS-CoV-2 Neutralization Antibody Detection Kit is a laboratory-developed test to specifically detect neutralizing antibodies in people who have been previously infected with COVID-19 or have been vaccinated.
Demonstrated 100% concordance with bioassay, which is considered the gold standard for evaluation of NAb activity.
Comparison of numerical results in titer levels will help determine how the immune response develops in an individual and persists over time.
Measuring the number of neutralization antibodies is one of the key parameters for evaluating SARS-CoV-2 vaccines.
The test assesses multiple antibody types against multiple SARS-CoV-2 antigens. It offers a view of multiple immune parameters in a single test, eliminating the need for multiple tests. It is also designed to measure levels of neutralizing antibodies, which measure the ability of antibodies to block COVID viral entry into cells. Levels of neutralizing antibodies have been used as an indicator of protective immunity.